GB9116896D0 - 3-deoxymannosamine derivatives and process for their preparation - Google Patents

3-deoxymannosamine derivatives and process for their preparation

Info

Publication number
GB9116896D0
GB9116896D0 GB919116896A GB9116896A GB9116896D0 GB 9116896 D0 GB9116896 D0 GB 9116896D0 GB 919116896 A GB919116896 A GB 919116896A GB 9116896 A GB9116896 A GB 9116896A GB 9116896 D0 GB9116896 D0 GB 9116896D0
Authority
GB
United Kingdom
Prior art keywords
deoxymannosamine
derivatives
preparation
deoxymannosamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919116896A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB919116896A priority Critical patent/GB9116896D0/en
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Publication of GB9116896D0 publication Critical patent/GB9116896D0/en
Priority to HU9202329A priority patent/HU213208B/hu
Priority to IL10250092A priority patent/IL102500A/en
Priority to AU20374/92A priority patent/AU646173B2/en
Priority to NZ243627A priority patent/NZ243627A/xx
Priority to MX9204395A priority patent/MX9204395A/es
Priority to US07/922,229 priority patent/US5332756A/en
Priority to TW081106118A priority patent/TW248564B/zh
Priority to FI923498A priority patent/FI923498L/fi
Priority to MYPI92001390A priority patent/MY108749A/en
Priority to KR1019920013968A priority patent/KR930004325A/ko
Priority to EP92307151A priority patent/EP0527042A2/en
Priority to JP4227760A priority patent/JPH05208988A/ja
Priority to ZA925871A priority patent/ZA925871B/xx
Priority to CA002075336A priority patent/CA2075336A1/en
Priority to SU925052492A priority patent/RU2099333C1/ru
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GB919116896A 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation Pending GB9116896D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation
HU9202329A HU213208B (en) 1991-08-06 1992-07-15 Process for preparing 3-deoxy-mannosamine derivatives and pharmaceutical compns. contg. them
IL10250092A IL102500A (en) 1991-08-06 1992-07-15 3-deoxy-mannosamine derivatives their preparation and pharmaceutical compositions containing them
AU20374/92A AU646173B2 (en) 1991-08-06 1992-07-17 3-deoxy-mannosamine derivatives and process for their preparation
NZ243627A NZ243627A (en) 1991-08-06 1992-07-20 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors
MX9204395A MX9204395A (es) 1991-08-06 1992-07-27 Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
US07/922,229 US5332756A (en) 1991-08-06 1992-07-31 3-deoxy-mannosamine derivatives
TW081106118A TW248564B (enExample) 1991-08-06 1992-08-01
FI923498A FI923498L (fi) 1991-08-06 1992-08-03 Foerfarande foer framstaellning av 3-deoximannosaminderivat
MYPI92001390A MY108749A (en) 1991-08-06 1992-08-04 3-deoxy-mannosamine derivatives and process for their preparation.
KR1019920013968A KR930004325A (ko) 1991-08-06 1992-08-04 3-데옥시-만노사민 유도체 및 이의 제조방법.
EP92307151A EP0527042A2 (en) 1991-08-06 1992-08-05 3-deoxy-mannosamine derivatives and process for their preparation
JP4227760A JPH05208988A (ja) 1991-08-06 1992-08-05 ３−デオキシマンノサミン誘導体およびそれら誘導体の製法
ZA925871A ZA925871B (en) 1991-08-06 1992-08-05 3-deoxy-mannosamine derivatives and process for their preparation
CA002075336A CA2075336A1 (en) 1991-08-06 1992-08-05 3-deoxy-mannosamine derivatives and process for their preparation
SU925052492A RU2099333C1 (ru) 1991-08-06 1992-08-05 Производное 3-дезоксиманнозамина, способ его получения и фармацевтическая композиция, обладающая ингибирующей активностью к развитию сосудов и метастазов

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
GB9116896D0 true GB9116896D0 (en) 1991-09-18

Family

ID=10699545

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919116896A Pending GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Country Status (16)

Country Link
US (1) US5332756A (enExample)
EP (1) EP0527042A2 (enExample)
JP (1) JPH05208988A (enExample)
KR (1) KR930004325A (enExample)
AU (1) AU646173B2 (enExample)
CA (1) CA2075336A1 (enExample)
FI (1) FI923498L (enExample)
GB (1) GB9116896D0 (enExample)
HU (1) HU213208B (enExample)
IL (1) IL102500A (enExample)
MX (1) MX9204395A (enExample)
MY (1) MY108749A (enExample)
NZ (1) NZ243627A (enExample)
RU (1) RU2099333C1 (enExample)
TW (1) TW248564B (enExample)
ZA (1) ZA925871B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
FR2723947B1 (fr) * 1994-08-31 1996-09-27 Adir Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2266734C2 (ru) * 1999-05-13 2005-12-27 Фарма Мар, С.А. Композиции и применение ет743 для лечения злокачественных опухолей
EP1757296A4 (en) * 2004-05-26 2010-09-01 Rare Sugar Production Technica METHOD FOR CONTROLLING THE PROLIFERATION OF TISSUE ENDHELICELLS AND INHIBITION OF LUMENING
JP2008509886A (ja) * 2004-06-23 2008-04-03 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 多糖誘導体および免疫応答の誘導における用途
US8148335B2 (en) * 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
JP2009530311A (ja) * 2006-03-15 2009-08-27 トラスティーズ オブ タフツ カレッジ 腫瘍の可視化、組織工学、および癌化学療法におけるフッ化炭水化物およびそれらの使用
KR100780868B1 (ko) 2006-07-10 2007-11-30 부경대학교 산학협력단 항암효과를 나타내는 4급 아미노 글루코사민 화합물
EP2173166A4 (en) * 2007-07-03 2010-08-11 Childrens Hosp & Res Ct Oak POLYSIALIC ACID DE-N-ACETYLASE HEMMER AND METHOD OF USE THEREOF
EP2173759A4 (en) 2007-07-03 2014-01-29 Childrens Hosp & Res Ct Oak OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE
EP2183261A4 (en) 2007-07-03 2010-09-15 Childrens Hosp & Res Ct Oak POLYSIALYLIC ACID DERIVATIVES, MANUFACTURING METHODS AND APPLICATIONS FOR INCREASING THE PRODUCTION AND TARGETING OF CANCER ANIMALS
FR2930943B1 (fr) * 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3906174A1 (de) * 1989-02-28 1990-08-30 Forschungszentrum Juelich Gmbh Verfahren zur herstellung von d-mannosaminderivaten

Also Published As

Publication number Publication date
IL102500A (en) 1996-01-19
HUT62593A (en) 1993-05-28
EP0527042A3 (enExample) 1994-01-05
FI923498A0 (fi) 1992-08-03
RU2099333C1 (ru) 1997-12-20
FI923498A7 (fi) 1993-02-07
IL102500A0 (en) 1993-01-14
NZ243627A (en) 1994-04-27
EP0527042A2 (en) 1993-02-10
CA2075336A1 (en) 1993-02-07
JPH05208988A (ja) 1993-08-20
US5332756A (en) 1994-07-26
KR930004325A (ko) 1993-03-22
MX9204395A (es) 1993-02-01
AU2037492A (en) 1993-02-11
FI923498L (fi) 1993-02-07
HU213208B (en) 1997-03-28
TW248564B (enExample) 1995-06-01
MY108749A (en) 1996-11-30
AU646173B2 (en) 1994-02-10
HU9202329D0 (en) 1992-10-28
ZA925871B (en) 1993-04-28

Similar Documents

Publication Publication Date Title
EG19752A (en) Dialkoxy-pyridinyl-benzimidazole derivatives process for their preparation and their pharmaceutical use
IL101865A0 (en) Thiopyranopyrrole derivatives and their preparation
IL121465A0 (en) 2-thiohydantoin derivatives and process for their preparation
SK60895A3 (en) Taxane derivatives and process for their preparation
EP0499233A3 (en) Organopentasiloxane and method for its preparation
SG42942A1 (en) Imidazopyridine derivatives and process for preparation thereof
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
HU9400478D0 (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
GB9116896D0 (en) 3-deoxymannosamine derivatives and process for their preparation
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
GB9121776D0 (en) Benzimidazole derivatives and process for preparation thereof
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
GB9204945D0 (en) 3-aryl-glycidic ester derivatives and process for their preparation
HUT66140A (en) New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof
ZA911927B (en) Labdanes and process for their preparation
CS199791A3 (en) Aminodiole derivatives and process for preparing thereof
IL96127A0 (en) Triazole derivatives and process for their preparation
IL116968A0 (en) Ethyl 6-trichloroacetimidoxy-4-hexenoate and the process for the preparation thereof
GB9201224D0 (en) Difluoromethylenandrostenone derivatives and process for their preparation
GB9127401D0 (en) Arylidene-homophthalimide derivatives and process for their preparation
GB9201286D0 (en) 3-methyleneandrostane derivatives and process for their preparation
GB9224188D0 (en) Imidazolyalkyl-imidazolidinone derivatives and process for their preparation
GB9108329D0 (en) Azacyclic derivatives and process for their preparation
GB9016704D0 (en) Pyrimidoindole derivatives and processes for preparation thereof